Sara Lauria serves as the Vice President of Global Partners for Europe at Catalent Pharma Solutions since February 2021. Prior experience includes positions at Zambon, where responsibilities encompassed leading corporate business development, in-licensing, co-development, and M&A activities, notably managing the acquisition of Breath Therapeutics valued at up to 500 million euros. Earlier roles at Italfarmaco involved managing the Industrial Development Group and project leadership in pharmaceutical technology, while initial experience began as an Associate Scientist at Pharmacia. Sara Lauria holds a Bachelor's degree in Medicinal and Pharmaceutical Chemistry from Università degli Studi di Milano and has additional education at The School of Pharmacy, University of London.